Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
Lafon E, Diem G, Witting C, Zaderer V, Bellmann-Weiler RM, Reindl M, Bauer A, Griesmacher A, Fux V, Hoermann G, Miller C, Zabernigg A, Wöll E, Wilflingseder D, Lass-Flörl C, Posch W.
Lafon E, et al. Among authors: witting c.
Front Immunol. 2021 Jun 14;12:684014. doi: 10.3389/fimmu.2021.684014. eCollection 2021.
Front Immunol. 2021.
PMID: 34194438
Free PMC article.